Paris, France

Emmanuel Guerin

This inventor holds 1 USPTO granted patent. Top assignee: Laboratoire Des Produits Ethiques Ethypharm. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emmanuel Guerin. Retrieved from https://idiyas.com/inventor/emmanuel-guerin-eybiyo1d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Emmanuel Guerin: Innovator in Pharmaceutical Solutions

Introduction

Emmanuel Guerin is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative approach to drug formulation. His work focuses on improving the delivery and efficacy of medications.

Latest Patents

Emmanuel Guerin holds a patent for a drinkable ibuprofen pharmaceutical suspension. This invention relates to a drinkable ibuprofen solution wherein the soluble fraction of the active ingredient contained therein is less than 10% by weight in relation to the weight of the suspension. This formulation aims to enhance the usability and effectiveness of ibuprofen for patients.

Career Highlights

Guerin is associated with Laboratoire des Produits Ethiques Ethypharm, where he applies his expertise in pharmaceutical development. His work at this company has allowed him to focus on creating ethical and effective pharmaceutical products that meet the needs of consumers.

Collaborations

Emmanuel has collaborated with several professionals in his field, including Christophe Lebon and Pascal Suplie. These collaborations have contributed to the advancement of his projects and the successful development of innovative pharmaceutical solutions.

Conclusion

Emmanuel Guerin's contributions to the pharmaceutical industry, particularly through his patent for a drinkable ibuprofen suspension, highlight his commitment to innovation and improving patient care. His work continues to influence the field and pave the way for future advancements in drug formulation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…